Antibacterial Drug Discovery: Some Assembly Required

ACS Infectious Diseases
Rubén TommasiAlita A Miller

Abstract

Our limited understanding of the molecular basis for compound entry into and efflux out of Gram-negative bacteria is now recognized as a key bottleneck for the rational discovery of novel antibacterial compounds. Traditional, large-scale biochemical or target-agnostic phenotypic antibacterial screening efforts have, as a result, not been very fruitful. A main driver of this knowledge gap has been the historical lack of predictive cellular assays, tools, and models that provide structure-activity relationships to inform optimization of compound accumulation. A variety of recent approaches has recently been described to address this conundrum. This Perspective explores these approaches and considers ways in which their integration could successfully redirect antibacterial drug discovery efforts.

References

Aug 1, 1986·The Journal of Infectious Diseases·J P QuinnS A Lerner
Nov 1, 1982·Journal of Bacteriology·F Yoshimura, H Nikaido
Jul 27, 2002·Annual Review of Microbiology·Robert E W Hancock, Fiona S L Brinkman
Jan 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jianwei MiaoYoshinori Nishino
Apr 18, 2003·Frontiers in Bioscience : a Journal and Virtual Library·Sandeep Tamber, Robert E W Hancock
Dec 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Hiroshi Nikaido
Dec 15, 2005·Journal of Bacteriology·Sandeep TamberRobert E W Hancock
Feb 24, 2006·Journal of the American Chemical Society·Taha RezaiR Scott Lokey
Dec 13, 2006·Nature Reviews. Drug Discovery·David J PayneDavid L Pompliano
Feb 12, 2008·Journal of Medicinal Chemistry·Rosemarie O'Shea, Heinz E Moser
Jul 2, 2008·Nature Reviews. Drug Discovery·Edward M DriggersNicholas K Terrett
Jan 21, 2010·Journal of Biomolecular Screening·Kozhinjampara R MahendranMathias Winterhalter
Feb 18, 2010·Antimicrobial Agents and Chemotherapy·Siew Ping Lim, Hiroshi Nikaido
Nov 10, 2010·Annals of the New York Academy of Sciences·Michael N GwynnDavid J Payne
Aug 9, 2011·Expert Review of Anti-infective Therapy·Sheo B SinghLynn Miesel
May 23, 2012·Expert Opinion on Drug Discovery·Herbert P Schweizer
Jul 25, 2012·Biochimica Et Biophysica Acta·Jiaming LiuLiviu Movileanu
Oct 5, 2012·Clinical Microbiology Reviews·Lucía Fernández, Robert E W Hancock
Mar 8, 2013·The Journal of Biological Chemistry·Elif ErenBert van den Berg
Jun 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Seiji Kojima, Hiroshi Nikaido
Jul 3, 2013·Annual Review of Microbiology·Philip HinchliffeVassilis Koronakis
Jul 3, 2013·Nature·Ryosuke NakashimaAkihito Yamaguchi
May 7, 2014·Annals of the New York Academy of Sciences·John H RexCarrie Harney
Jun 6, 2014·Biochemistry·Hossein Heidari TorkabadiPaul R Carey
Nov 19, 2014·Future Microbiology·Jessica M A BlairLaura J V Piddock
Mar 20, 2015·Clinical Microbiology Reviews·Xian-Zhi LiHiroshi Nikaido
Apr 25, 2015·Chemistry & Biology·Vincent M IsabellaAlita A Miller
Jun 27, 2015·Frontiers in Microbiology·João AnesMarta Martins
Jul 4, 2015·Nature Reviews. Drug Discovery·Ruben TommasiAlita A Miller
Jul 29, 2015·Frontiers in Microbiology·Jürg Dreier, Paolo Ruggerone
Dec 10, 2015·The Journal of Biological Chemistry·Harsha BajajMathias Winterhalter
Jan 26, 2016·Structure·Michael ZahnBert van den Berg
Feb 13, 2016·Nature Communications·Laetitia DauryOlivier Lambert
Mar 16, 2016·Proceedings of the National Academy of Sciences of the United States of America·Hanno SjutsTimothy J Opperman
Apr 27, 2016·Current Opinion in Biotechnology·Andrew C PawlowskiGerard D Wright
Jul 7, 2016·Bioorganic & Medicinal Chemistry·Lynn L Silver

❮ Previous
Next ❯

Citations

Apr 6, 2019·Physical Chemistry Chemical Physics : PCCP·Joan CoinesMatteo Ceccarelli
Sep 22, 2018·Nature Chemistry·Jed F Fisher, Shahriar Mobashery
Mar 11, 2020·The Journal of Antibiotics·Mark S Butler, David L Paterson
May 2, 2020·Antibiotics·Paul S Hoffman
Oct 6, 2018·MedChemComm·Kamaleddin H M E Tehrani, Nathaniel I Martin
Dec 6, 2019·MedChemComm·Aurijit Sarkar, Sylvie Garneau-Tsodikova
Oct 3, 2020·Biochemical Society Transactions·Nicolò ParaciniJeremy H Lakey
Nov 18, 2020·Nature Chemical Biology·Shibin ZhaoDerek S Tan
Feb 17, 2021·ChemMedChem·Clinton G L Veale
Feb 27, 2021·Accounts of Chemical Research·Kristen A Muñoz, Paul J Hergenrother
Jun 3, 2021·Antibiotics·Silvia Acosta-GutiérrezMatteo Ceccarelli
Jul 3, 2018·ACS Infectious Diseases·Ramkumar IyerAlice L Erwin
May 21, 2020·Journal of the American Chemical Society·Stephen E MotikaPaul J Hergenrother
Jan 10, 2019·ACS Infectious Diseases·Marcella WidyaDavid A Six
Nov 30, 2018·Analytical Chemistry·Hans ProchnowMark Brönstrup
Jul 8, 2020·Journal of Medicinal Chemistry·Colin K SkepperAlexey Rivkin
Nov 25, 2020·ACS Infectious Diseases·Sarah J PerlmutterPaul J Hergenrother
Nov 23, 2021·ACS Chemical Biology·Wesley G CochraneBrian M Paegel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Pharmacology
J C Somberg
Innovations in Clinical Neuroscience
Adegboyega Oyemade
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme
T Sakurai
© 2022 Meta ULC. All rights reserved